Browsing by Yonsei Author : Park, Jun Yong

eperson profile image
Name:
Park, Jun Yong [박준용]
orcid http://orcid.org/0000-0001-6324-2224
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (47861376300)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 416

This table browses all dspace content
Issue DateTitleJournal Title
2023Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratification HEPATOBILIARY SURGERY AND NUTRITION
2023Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating L-arginine production EXPERIMENTAL AND MOLECULAR MEDICINE
2023Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma CELL COMMUNICATION AND SIGNALING
2023MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related CirrhosisCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2023Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis BLIVER INTERNATIONAL
2023Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study JHEP REPORTS
2023The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNAJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBPAMERICAN JOURNAL OF GASTROENTEROLOGY
2023Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver diseaseLIVER INTERNATIONAL
2023Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models BIOMEDICINE & PHARMACOTHERAPY
2023Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinomaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2023Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis DIAGNOSTICS
2023Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping NATURE COMMUNICATIONS
2023Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel DiseGUT AND LIVER
2022Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinomaLIVER INTERNATIONAL
2022Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner JOURNAL OF HEPATOLOGY
2022Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology Journal of Liver Cancer(대한간암학회지)
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model GASTROENTEROLOGY REPORT
2022Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis BDIGESTIVE DISEASES AND SCIENCES
2022Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) CANCERS
2022Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis CANCERS
2022Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels JOURNAL OF HEPATOLOGY
2022KASL clinical practice guidelines for management of chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2022Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria FRONTIERS IN MEDICINE
2022Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter studyJOURNAL OF VIRAL HEPATITIS
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Impaired antibacterial response of liver sinusoidal Vγ9 + Vδ2 + T cells in patients with chronic liver diseaseGUT
2022Predictors of Sarcopenia in an Obese Asian PopulationNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2022A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling AMERICAN JOURNAL OF CANCER RESEARCH
2022External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study CANCERS
2022Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis DIAGNOSTICS
2022Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mLAMERICAN JOURNAL OF GASTROENTEROLOGY
2022Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitisRHEUMATOLOGY INTERNATIONAL
2022Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents SCIENTIFIC REPORTS
2022Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization CANCERS
2022Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis BJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2022Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients CANCERS
2021Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis BEXPERT OPINION ON PHARMACOTHERAPY
2021Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy CANCERS
2021No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal ActivationHEPATOLOGY
2021Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma AMERICAN JOURNAL OF CANCER RESEARCH
2021Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2021Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis BJOURNAL OF VIRAL HEPATITIS

Browse

Links